Robert R. Henry MD
Diabetes, Lipid Metabolism
Professor of Medicine, University of California San Diego and Chief, Section of Diabetes, VA San Diego
Join to View Full Profile
3350 La Jolla Village Dr111gSan Diego, CA 92161
Phone+1 858-642-3648
Fax+1 858-642-6242
Dr. Henry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ManitobaClass of 1975
Certifications & Licensure
CA State Medical License 1984 - 2020
Clinical Trials
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- 12 citationsAstaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia.Theodore P Ciaraldi, Schafer C Boeder, Sunder R Mudaliar, Erin R Giovannetti, Robert R Henry
Diabetes, Obesity & Metabolism. 2023-07-01 - 2 citationsAdipose tissue from subjects with type 2 diabetes exhibits impaired capillary formation in response to GROα: involvement of MMPs-2 and -9.Yifat Amir Levy, Theodore P Ciaraldi, Sunder R Mudaliar, Susan A Phillips, Robert R Henry
Adipocyte. 2022-12-01 - 7 citationsp300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytesVitor F. Martins, Samuel LaBarge, Alexandra Stanley, Kristoffer Svensson, Chao-Wei Hung
JCI Insight. 2021-11-23
Journal Articles
- Correction to: Mitochondrial H+-ATP Synthase in Human Skeletal Muscle: Contribution to Dyslipidaemia and Insulin ResistancePam Taub, Robert R Henry, Diabetologia
Press Mentions
Elcelyx Therapeutics Reports Positive Results in Phase 2b Study of Metformin Delayed Release in Type 2 DiabetesNovember 11th, 2016
American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of Sglt-2 Inhibitors and Diabetic KetoacidosisApril 16th, 2016
REMD Biotherapeutics Announces Dosing of First Type 1 Diabetes Patient with REMD-477, a Glucagon Receptor Monoclonal AntibodyApril 6th, 2016- Join now to see all
Committees
- member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
- member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
- member, American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
